ARCELLX INC's ticker is and the CUSIP is 03940C100. A total of 168 filers reported holding ARCELLX INC in Q2 2024. The put-call ratio across all filers is 1.00 and the average weighting 0.7%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 3,146,630 | $174,637,965 | 73.33% |
| NEA Management Company, LLC | 3,745,262 | $207,862,041 | 13.85% |
| Paradigm Biocapital Advisors LP | 3,658,624 | $203,053,632 | 9.51% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,435,974 | $135,196,557 | 6.11% |
| Perceptive Advisors | 4,544,809 | $252,236,900 | 5.63% |
| STEMPOINT CAPITAL LP | 313,604 | $17,405,022 | 4.64% |
| Cormorant Asset Management, LP | 1,700,000 | $94,350,000 | 4.51% |
| Samsara BioCapital, LLC | 460,441 | $25,554,476 | 3.98% |
| Affinity Asset Advisors, LLC | 340,000 | $18,870,000 | 3.45% |
| ACUTA CAPITAL PARTNERS, LLC | 77,000 | $4,273,500 | 2.41% |